These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 6514131

  • 1. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ, Morris M, Haywood JR.
    Neuroendocrinology; 1984 Nov; 39(5):429-36. PubMed ID: 6514131
    [Abstract] [Full Text] [Related]

  • 2. GABA agonists inhibit central sodium-induced vasopressin-dependent increases in arterial pressure.
    Brennan TJ, Morris M, Haywood JR.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):223-34. PubMed ID: 6489442
    [Abstract] [Full Text] [Related]

  • 3. GABA inhibition of central angiotensin II and hypertonic CSF pressor responses.
    Brennan TJ, Haywood JR.
    Brain Res; 1983 May 16; 267(2):261-9. PubMed ID: 6871675
    [Abstract] [Full Text] [Related]

  • 4. Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin.
    Unger T, Bles F, Ganten D, Lang RE, Rettig R, Schwab NA.
    Eur J Pharmacol; 1983 May 20; 90(1):1-9. PubMed ID: 6873170
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB, Bennett T, Randall MD, Gardiner SM.
    Br J Pharmacol; 1998 Apr 20; 123(7):1367-74. PubMed ID: 9579732
    [Abstract] [Full Text] [Related]

  • 6. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H, Sharabi FM, O'Connor G, Mark AL, Schmid PG.
    Clin Exp Hypertens A; 1982 Apr 20; 4(8):1303-21. PubMed ID: 7116668
    [Abstract] [Full Text] [Related]

  • 7. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P, Kasson BG, Brody MJ.
    Hypertension; 1989 Jun 20; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [Abstract] [Full Text] [Related]

  • 8. Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat.
    Bisset GW, Chowdrey HS, Fairhall KM, Gunn LK.
    Br J Pharmacol; 1990 Mar 20; 99(3):529-35. PubMed ID: 2331582
    [Abstract] [Full Text] [Related]

  • 9. Arginine vasopressin modulates the central action of angiotensin II in the dog.
    Michelini LC, Barnes KL, Ferrario CM.
    Hypertension; 1983 Mar 20; 5(6 Pt 3):V94-100. PubMed ID: 6654469
    [Abstract] [Full Text] [Related]

  • 10. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P, Becker H, Dietrich R, Luft F, Unger T.
    J Cardiovasc Pharmacol; 1986 Mar 20; 8(4):689-96. PubMed ID: 2427805
    [Abstract] [Full Text] [Related]

  • 11. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.
    Grant TL, McGrath JC.
    Br J Pharmacol; 1988 Dec 20; 95(4):1220-8. PubMed ID: 3146400
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function.
    Fisher LA, Brown MR.
    Brain Res; 1984 Mar 26; 296(1):41-7. PubMed ID: 6608972
    [Abstract] [Full Text] [Related]

  • 13. The role of GABA in the central regulation of AVP and ANP release and blood pressure due to angiotensin and carbachol, and central GABA release due to blood pressure changes.
    Kimura T, Funyu T, Ohta M, Yamamoto T, Ota K, Shoji M, Inoue M, Sato K, Abe K.
    J Auton Nerv Syst; 1994 Dec 01; 50(1):21-9. PubMed ID: 7844311
    [Abstract] [Full Text] [Related]

  • 14. Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin II.
    Bealer SL, Phillips MI, Johnson AK, Schmid PG.
    Am J Physiol; 1979 Jun 01; 236(6):E610-5. PubMed ID: 443416
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D, Gardiner SM, Bennett T.
    Brain Res; 1988 Jul 05; 455(1):58-64. PubMed ID: 3416193
    [Abstract] [Full Text] [Related]

  • 16. Effects of intraventricular angiotensin II mediated by the sympathetic nervous system.
    Falcon JC, Phillips MI, Hoffman WE, Brody MJ.
    Am J Physiol; 1978 Oct 05; 235(4):H392-9. PubMed ID: 696880
    [Abstract] [Full Text] [Related]

  • 17. Interrelationship between central bradykinin and vasopressin in conscious rats.
    Brooks DP, Share L, Crofton JT, Nasjletti A.
    Brain Res; 1986 Apr 16; 371(1):42-8. PubMed ID: 3754782
    [Abstract] [Full Text] [Related]

  • 18. The effect of a vasopressin antagonist on the pressor response to histamine administered centrally.
    Gatti PJ, Gertner SB.
    Neuropharmacology; 1983 Jul 16; 22(7):895-902. PubMed ID: 6688661
    [Abstract] [Full Text] [Related]

  • 19. GABAergic inhibition of hypertonic saline-induced vasopressin-dependent hypertension.
    Brennan TJ, Haywood JR.
    J Pharmacol Exp Ther; 1985 Jun 16; 233(3):663-71. PubMed ID: 4009486
    [Abstract] [Full Text] [Related]

  • 20. Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system.
    Ohnishi A, Li P, Branch RA, Holycross B, Jackson EK.
    J Clin Invest; 1987 Jul 16; 80(1):13-6. PubMed ID: 3110209
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.